BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33039698)

  • 1. Combinatorial mutagenesis with alternative CDR-L1 and -H2 loop lengths contributes to affinity maturation of antibodies.
    Brockmann EC; Pyykkö M; Hannula H; Khan K; Lamminmäki U; Huovinen T
    N Biotechnol; 2021 Jan; 60():173-182. PubMed ID: 33039698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a scFv Library with Synthetic, Non-combinatorial CDR Diversity.
    Bai X; Shim H
    Methods Mol Biol; 2017; 1575():15-29. PubMed ID: 28255872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potential.
    Mahon CM; Lambert MA; Glanville J; Wade JM; Fennell BJ; Krebs MR; Armellino D; Yang S; Liu X; O'Sullivan CM; Autin B; Oficjalska K; Bloom L; Paulsen J; Gill D; Damelin M; Cunningham O; Finlay WJ
    J Mol Biol; 2013 May; 425(10):1712-30. PubMed ID: 23429058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and analysis of the improved human HAL9/10 antibody phage display libraries.
    Kügler J; Wilke S; Meier D; Tomszak F; Frenzel A; Schirrmann T; Dübel S; Garritsen H; Hock B; Toleikis L; Schütte M; Hust M
    BMC Biotechnol; 2015 Feb; 15():10. PubMed ID: 25888378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Human scFv Library with Non-Combinatorial Synthetic CDR Diversity.
    Bai X; Kim J; Kang S; Kim W; Shim H
    PLoS One; 2015; 10(10):e0141045. PubMed ID: 26484868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs.
    Tiller KE; Li L; Kumar S; Julian MC; Garde S; Tessier PM
    J Biol Chem; 2017 Oct; 292(40):16638-16652. PubMed ID: 28778924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation sequencing-guided identification and reconstruction of antibody CDR combinations from phage selection outputs.
    Barreto K; Maruthachalam BV; Hill W; Hogan D; Sutherland AR; Kusalik A; Fonge H; DeCoteau JF; Geyer CR
    Nucleic Acids Res; 2019 May; 47(9):e50. PubMed ID: 30854567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective Optimization of Antibody Affinity by Phage Display Integrated with High-Throughput DNA Synthesis and Sequencing Technologies.
    Hu D; Hu S; Wan W; Xu M; Du R; Zhao W; Gao X; Liu J; Liu H; Hong J
    PLoS One; 2015; 10(6):e0129125. PubMed ID: 26046845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro affinity maturation of an anti-PSA antibody for prostate cancer diagnostic assay.
    Muller BH; Savatier A; L'Hostis G; Costa N; Bossus M; Michel S; Ott C; Becquart L; Ruffion A; Stura EA; Ducancel F
    J Mol Biol; 2011 Dec; 414(4):545-62. PubMed ID: 22019475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short Read-Length Next Generation DNA Sequencing of Antibody CDR Combinations from Phage Selection Outputs.
    Pastushok L; Barreto K; Geyer CR
    Methods Mol Biol; 2022; 2313():127-141. PubMed ID: 34478134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.
    Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE
    J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel heavy domain antibody library with functionally optimized complementarity determining regions.
    Mandrup OA; Friis NA; Lykkemark S; Just J; Kristensen P
    PLoS One; 2013; 8(10):e76834. PubMed ID: 24116173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries.
    Cembrola B; Ruzza V; Troise F; Esposito ML; Sasso E; Cafaro V; Passariello M; Visconte F; Raia M; Del Vecchio L; D'Alise AM; Cortese R; Scarselli E; Zambrano N; De Lorenzo C; Nicosia A
    Biomed Res Int; 2019; 2019():6051870. PubMed ID: 31976323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity maturation of antibodies by combinatorial codon mutagenesis versus error-prone PCR.
    Simons JF; Lim YW; Carter KP; Wagner EK; Wayham N; Adler AS; Johnson DS
    MAbs; 2020; 12(1):1803646. PubMed ID: 32744131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.
    Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G
    J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substitution of Heavy Complementarity Determining Region 3 (CDR-H3) Residues Can Synergistically Enhance Functional Activity of Antibody and Its Binding Affinity to HER2 Antigen.
    Moon SK; Park SR; Park A; Oh HM; Shin HJ; Jeon EJ; Kim S; Park HJ; Yeon YJ; Yoo YJ
    Mol Cells; 2016 Mar; 39(3):217-28. PubMed ID: 26743905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Single-Framework Synthetic Antibody Library Containing a Combination of Canonical and Variable Complementarity-Determining Regions.
    Maruthachalam BV; El-Sayed A; Liu J; Sutherland AR; Hill W; Alam MK; Pastushok L; Fonge H; Barreto K; Geyer CR
    Chembiochem; 2017 Nov; 18(22):2247-2259. PubMed ID: 28884521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare, high-affinity mouse anti-PD-1 antibodies that function in checkpoint blockade, discovered using microfluidics and molecular genomics.
    Adler AS; Mizrahi RA; Spindler MJ; Adams MS; Asensio MA; Edgar RC; Leong J; Leong R; Johnson DS
    MAbs; 2017; 9(8):1270-1281. PubMed ID: 28846506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
    Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
    J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery.
    Fennell BJ; McDonnell B; Tam AS; Chang L; Steven J; Broadbent ID; Gao H; Kieras E; Alley J; Luxenberg D; Edmonds J; Fitz LJ; Miao W; Whitters MJ; Medley QG; Guo YJ; Darmanin-Sheehan A; Autin B; Shúilleabháin DN; Cummins E; King A; Krebs MR; Grace C; Hickling TP; Boisvert A; Zhong X; McKenna M; Francis C; Olland S; Bloom L; Paulsen J; Somers W; Jensen A; Lin L; Finlay WJ; Cunningham O
    MAbs; 2013; 5(6):882-95. PubMed ID: 23995618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.